Home » Topics » Regulatory

Regulatory
RSS

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...